INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 38 filers reported holding INOZYME PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,330 | +18.2% | 53,888 | +56.7% | 0.00% | – |
| Q2 2023 | $191,547 | +1429.9% | 34,389 | +188.4% | 0.00% | – |
| Q4 2022 | $12,520 | -79.1% | 11,924 | -4.6% | 0.00% | – |
| Q2 2022 | $60,000 | +11.1% | 12,505 | -5.7% | 0.00% | – |
| Q1 2022 | $54,000 | -40.0% | 13,255 | +0.1% | 0.00% | – |
| Q4 2021 | $90,000 | -53.1% | 13,239 | -20.1% | 0.00% | – |
| Q3 2021 | $192,000 | -41.6% | 16,565 | -14.2% | 0.00% | – |
| Q2 2021 | $329,000 | -30.1% | 19,310 | -18.8% | 0.00% | – |
| Q1 2021 | $471,000 | +9.5% | 23,790 | +14.2% | 0.00% | – |
| Q4 2020 | $430,000 | +19.4% | 20,839 | +52.3% | 0.00% | – |
| Q3 2020 | $360,000 | – | 13,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,591,154 | $27,113,000 | 10.69% |
| Burrage Capital Management LLC | 242,517 | $4,132,000 | 4.14% |
| CHI Advisors LLC | 927,264 | $15,801,000 | 3.68% |
| Sofinnova Investments, Inc. | 2,028,308 | $34,562,000 | 1.99% |
| Novo Holdings A/S | 1,867,706 | $31,826,000 | 1.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,178,985 | $37,130,000 | 0.66% |
| RA Capital Management | 2,003,653 | $34,142,000 | 0.55% |
| NEA Management Company, LLC | 2,444,379 | $41,652,000 | 0.54% |
| Rock Springs Capital Management LP | 840,272 | $14,318,000 | 0.28% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 365,172 | $6,223,000 | 0.09% |